Israel’s Macrocure’s white blood cell injections treat hard-to-heal and chronic wounds. It wants to raise $75 million from an IPO on NASDAQ to finance its CureXcell a cell-based therapy that restores the natural balance required for the wound healing process.
http://www.globes.co.il/en/article-wound-treatment-co-macrocure-files-for-nasdaq-ipo-1000948771
https://www.youtube.com/watch?v=NIqc4NdJn7c